Merck hands over $20M in IBD drug target deal with Flagship's Quotient Read more 

Innovent sees path to China approval after eye disease drug matches Eylea in phase 3 Read more 

Fierce Biotech Fundraising Tracker '26: Immutrin's $87M series A; Crossbow targets $77M Read more 

Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health

“You Have to Be Completely Crazy” – Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health From the ER to entrepreneurship, [...]

2025-09-02T10:22:17+01:00July 29, 2025|
Go to Top